Induction Chemotherapy for Locally Advanced Esophageal Cancer
Research Question:
Will the use of mFOLFOX6 (5-Fluorouracil, Leucovorin and Oxaliplatin) chemotherapy
as induction treatment prior to standard neoadjuvant chemoradiation decrease the
rate of distant recurrence among patients with locally advanced esophageal cancer?
Basic Study Information
Purpose:
Evaluate mFOLFOX6 (5-Fluorouracil, Leucovorin and Oxaliplatin) chemotherapy as induction
treatment prior to standard neoadjuvant chemoradiation to decrease the rate of distant
recurrence among patients with locally advanced esophageal cancer.
Location: University of Rochester Medical Center
Study Reference #: UGIE17037
Lead Researcher (Principal Investigator)
Lead Researcher:
Richard Dunne
Study Contact Information
Study Coordinator: Tanya Smith
Phone: (585) 275-8213
Email: Tanya_Smith@URMC.Rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search